Magnetite Nanoparticle Development for Targeted Anti-Inflammatory Drug Delivery in Rheumatoid Arthritis

Authors

  • Vishwa S. Padole Associates Professor, G H Raisoni Institute of Life Sciences, Nagpur, Maharashtra, 440016, India Author
  • J. B. Veeramalini Associate Professor, Vel Tech High Tech Dr. Rangarajan Dr. Sakunthala Engineering College, Chennai, Tamilnadu, 600062, India Author
  • Dil Prasad Subba Department of Pharmacy, School of Pharmacy, Sharda University, Greater Noida, 201310, Uttar Pradesh, India Author
  • Ujwala Panditrao Mahale Assistant Professor, OBVs Prof. Ravindra Nikam College of Pharmacy Gondur, Dhule, Maharashtra, 424004, India Author
  • Ashish Ambadas Sabale Assistant Professor, School of Pharmacy, GH Raisoni University, Amravati, Maharashtra, 444701, India Author
  • Naresh S. Halke Assistant Professor, Dayanand College of Pharmacy, Latur, Maharashtra, 413512, India Author
  • David Blessing Rani J Assistant Professor, School of Pharmaceutical Sciences, Centurion University of Technology and Management, Vizianagaram, Andhra Pradesh, 535003, India Author
  • Mohammed Khalid Assistant Professor, R.L Jalappa College of Pharmacy Sri Devaraj URS Academy of Higher Education and Research, Kolar, Karnataka, 563101, India Author
  • N. Nagi Reddy Associate Professor, Srikrupa Institute of Pharmaceutical Sciences, Siddipet, Telangana, 502277, India Author

DOI:

https://doi.org/10.48047/g826qp16

Keywords:

Magnetite nanoparticles, targeted drug delivery, rheumatoid arthritis, anti-inflammatory drugs

Abstract

Introduction: About one percent of the world's population suffers with rheumatoid arthritis, a 
degenerative inflammatory disease that gradually destroys joints and causes severe pain and impairment. 
Because of their biocompatibility, controlled drug release capabilities, and superparamagnetic 
characteristics, magnetite nanoparticles have become attractive candidates for targeted medication 
delivery. In order to improve therapy outcomes in RA, this study seeks to create and describe magnetite 
nanoparticles that can deliver anti-inflammatory medicines to inflamed joints.

Downloads

Download data is not yet available.

Downloads

Published

2025-02-19

Issue

Vol. 54 No. 3 (2025): Year 2025, Volume 54, Issue 3

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  1. Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
  2. Adapt — remix, transform, and build upon the material for any purpose, even commercially.
  3. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

How to Cite

Magnetite Nanoparticle Development for Targeted Anti-Inflammatory Drug Delivery in Rheumatoid Arthritis (V. . S. Padole, J. B. Veeramalini, D. P. . Subba, U. Panditrao Mahale, A. Ambadas Sabale, N. S. Halke, D. Blessing Rani J, M. Khalid, & N. N. . Reddy , Trans.). (2025). Cuestiones De Fisioterapia, 54(3), 4722-4733. https://doi.org/10.48047/g826qp16